The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...
An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in ...
Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
EXCLUSIVE: When Canadian director Leah Nelson and producer Lauren Miller Rogen first read Sarah Leavitt’s graphic memoir ...
Today, an Alzheimer’s diagnosis is not the end, but the starting line for living intentionally, with more tools, treatments, ...
India Today on MSN
India gets first Alzheimer's drug amid debate over real benefits
Eli Lilly has launched Lormalzi, its donanemab treatment for early Alzheimer's disease, in India. The rollout opens a new ...
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β ...
Simple blood tests can now detect Alzheimer's before symptoms appear, but most Americans cannot access them because Medicare ...
A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, delivered in a one-time gene therapy ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results